RB1 and retinoblastoma: Jian Tu et al. used the CRISPR-Cas9 nickase system to create an RB1 heterozygous deletion in pluripotent H1 human embryonic stem cell line, which provides an exciting cell resource for further investigation of the etiology of retinoblastoma [155].